In heartworm disease, several biomarkers of cardiopulmonary injury and inflammatory
activity have been studied during the recent years. D-dimer is a fibrin degradation product …

Background Pulmonary hypertension (PH) can develop secondary to many common
cardiopulmonary diseases, and the use of sildenafil has improved care of affected dogs …

Thrombosis is a major cause of mortality and morbidity in humans and dogs; however, anti-
thrombotic drugs carry a risk of bleeding and increase the cost of patient care. The ability to …

Objective To evaluate the relationship between shortened prothrombin time (PT) or activated
partial thromboplastin time (aPTT) values, clinical findings associated with …

There is no evidence-based diagnostic approach for diagnosis of pulmonary
thromboembolism (PTE) in dogs. Many dogs with diseases that predispose to thrombosis …

Background Immune‐mediated hemolytic anemia (IMHA) in dogs has a high risk of
thrombosis and is associated with marked neutrophilia and necrosis. Cell death and release …

Pulmonary hypertension (PH) is the persistent abnormal increase in pulmonary artery (PA)
pressure and in dogs is usually secondary to congenital disease causing pulmonary over …

Background Factors associated with outcome in dogs diagnosed with infective endocarditis
(IE) are not well characterized. Objectives Evaluate outcome and prognostic factors in dogs …

Objective To describe the finding of the lung ultrasound (LUS)“wedge sign” in dogs with
presumptive pulmonary thromboembolism (PTE). Case Series Summary This case series …

Three dogs were diagnosed with right atrial thrombosis, thought to be secondary to systemic
diseases. Specifically, two cases had hyperadrenocorticism and one case was diagnosed …